ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform

GC 2400 solution streamlines performance and delivers superior precision for high throughput environments

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the GC 2400™ Platform, an advanced, automated gas chromatography (GC), headspace sampler and GC/mass spectrometry (GC/MS) solution designed to help lab teams simplify lab operations, drive precise results, and perform more flexible monitoring.

Created with productivity in mind for pharmaceutical, food, environmental and industrial analyses, the new platform brings together systems, software and a wide range of columns and consumables to meet customers’ varied workflow needs.

For high throughput lab environments and complex applications, the GC automated sampling capabilities reduces hands-on time and human error, and the industry-unique automated headspace/pneumatics technology delivers superior precision.

Monitoring single or multiple GC 2400 systems --inside or outside the lab -- is simple, using the wireless, touchscreen tablet interface running the PerkinElmer Simplicity Vision™ app.

The platform’s icon-driven, 21 CFR Part 11 compliant PerkinElmer SimplicityChrom™ Chromatography Data System (CDS) software reduces user training and guides teams through their entire GC workflow. The software interface is also customizable to address user’s unique data, notification and diagnostic needs.

With sustainability and safety in mind, built in sensors and a software-driven gas saver mode reduce operational gas consumption and support carrier gas alternatives such as hydrogen.

Commenting on the new offering, Suneet Chadha, VP and GM of Applied and Food Markets at PerkinElmer, said, “Today’s labs want their analytical workflows to command less time, attention and resources. Our new, automated GC 2400 Platform allows teams at any expertise level to better manage and monitor their GC analyses from sample through result so they can focus on high-value activities in their labs and businesses.”

PerkinElmer will highlight the new solution at Analytica Germany (Hall A2, booth 502) and Analytica Latin America (booth I037B) along with other offerings for life sciences, applied, diagnostics, food and more.

About PerkinElmer

PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5.0 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com. Follow PerkinElmer on LinkedIn, Twitter, Facebook, Instagram, and YouTube.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.